Latest Angiogenesis Stories
DUBLIN, May 19, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/qfxkcq/global_cell)
SAN DIEGO, May 15, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned operating unit of Taxus Cardium Pharmaceuticals Group (Symbol: CRXM), today announced a presentation at the 18(th)
LONDON, May 13, 2015 /PRNewswire/ -- Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"), its majority owned
SAN DIEGO, May 11, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc.
New Studies Identify Molecular Target, Mitochondria-Specific Effects of ME-344; Results from First-in-Human Clinical Study Published in Cancer SAN DIEGO, May 4, 2015 /PRNewswire/ --
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
Significant increases were shown in the protein Kallistatin, a potent vasodilator Purchase, NY (PRWEB) March 31, 2015 Nutrition 21, LLC (“Nutrition
Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Study CUMBERLAND, R.I., March 30, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.
DALLAS, March 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Myocardial Ischemia - Pipeline Review, H1 2015" therapeutic market research report provides an overview
Long Island Joins Atlanta, Chicago and Philadelphia Study Centers for CardioCell's Chronic Heart Failure Clinical Trial Using Ischemia-Tolerant Mesenchymal Stem Cells (itMSCs) STONY
- A hairdresser.